

According to a recent study published in the peer-reviewed Journal of Neurotrauma, over 30% of traumatic brain injury (TBI) patients who did not receive life-sustaining treatment (WLST) were able to regain some degree of independence.
Yelena Bodien, PhD, of Harvard Medical School and Massachusetts Hospital, together with her coauthors, issued a warning, stating that when the likelihood of WLST is high, death or serious disability is a frequent consequence. In patients who passed away following WLST, the authors looked into the chances of survival and independent recovery following severe traumatic brain injury. They made a comparison between acute TBI patients who passed away following WLST and those who did not have WLST removed.
Traditionally, decisions surrounding WLST withdrawal for TBI patients have been guided by the assumption of poor prognosis. This often leads families to opt for withdrawal, fearing a prolonged state of minimal consciousness or severe disability for their loved one. However, Dr. Bodien’s study challenges this notion. By demonstrating a significant possibility of regaining independence even after WLST is withheld, the research suggests the need for revised communication strategies. Doctors should focus on presenting a more nuanced prognosis, outlining the potential for meaningful recovery alongside the risks involved in forgoing WLST. This would empower families to make informed decisions based on a more complete picture of their loved one’s potential future.
“Our results support recent calls for a cautionary approach toward early WLST after acute TBI and suggest that a lifetime in a vegetative state or with a lower severe disability is not a common outcome, even after a very serious injury,” stated the investigators.
“My congratulations to Dr. Bodien and colleagues for this carefully articulated communication. Their findings have important implications for the practice of critical care medicine around the world. Everyone who is involved in the care of patients with acute ‘severe’ traumatic brain injury should read this article carefully.” – David L. Brody, MD, PhD, Editor-in-Chief of Journal of Neurotrauma
For more information: Recovery Potential in Patients Who Died After Withdrawal of Life-Sustaining Treatment: A TRACK-TBI Propensity Score Analysis, Journal of Neurotrauma, doi.org/10.1089/neu.2024.0014
more recommended stories
Brain’s High-Tech Fix for Blurry Vision During Movement
High-Tech Video Optimization in Our Brain:.
Air Pollution Hurts Brain Health in Just 4 Hours
Air Pollution Blurs the Mind, Impairs.
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders
Urgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences Division
The High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences Division
The installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences Division
Scientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences Division
Antimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences Division
The TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences Division
The research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences Division
Only 30 prizes are awarded throughout.
Leave a Comment